MiNK Therapeutics Insider Sales: Ryan Barbara’s 1,500‑Share Exit Highlights Valuation Concerns
MiNK Therapeutics insider trading: board member Ryan Barbara sold 1,500 shares at $10–$15, raising valuation questions amid a 2.48% weekly gain and 40% yearly rally.
3 minutes to read